Abstract
Spina bifida is a neurodevelopmental disorder that results in a broad range of disability. Over the last few decades, there have been significant advances in diagnosis and treatment of this condition, which have raised concerns regarding how clinicians prognosticate the extent of disability, determine quality of life, and use that information to make treatment recommendations. From the selective treatment of neonates in the 1970s, to the advent of maternal–fetal surgery today, the issues that have been raised surrounding spina bifida intervention invoke principles of medical bioethics such as beneficence and nonmaleficence, while also highlighting how quality of life judgments may drive care decisions. Such changes in treatment norms are also illustrative of how disability is viewed both within the medical community and by society at large. An examination of the changes in spina bifida treatment provides a model through which to understand how ethically complex decisions regarding care for children with disabilities has evolved, and the challenges faced when medical information is combined with value-based judgments to guide medical decision making.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Adzick, N. S., Thom, E. A., Spong, C. Y., Brock, J. W., III, Burrows, P. K., Johnson, M. P., et al. (2011). A randomized trial of prenatal versus postnatal repair of myelomeningocele. New England Journal of Medicine, 364(11), 993–1004. doi:10.1056/NEJMoa1014379.
American Academy of Pediatrics Committee on Bioethics. (1983). Treatment of critically ill newborns. Pediatrics, 72(4), 565–566.
Antiel, R. M. (2016). Ethical challenges in the new world of maternal–fetal surgery. Seminars in Perinatology, 40(4), 227–233. doi:10.1053/j.semperi.2015.12.012.
Bakaniene, I., Prasauskiene, A., & Vaiciene-Magistris, N. (2016). Health-related quality of life in children with myelomeningocele: A systematic review of the literature. Child: Care, Health and Development, 42(5), 625–643. doi:10.1111/cch.12367.
Barry, S. (2010). Quality of life and myelomeningocele: An ethical and evidence-based analysis of the Groningen Protocol. Pediatric Neurosurgery, 46(6), 409–414. doi:10.1159/000322895.
Brown, S. D., Donelan, K., Martins, Y., Burmeister, K., Buchmiller, T. L., Sayeed, S. A., et al. (2012). Differing attitudes toward fetal care by pediatric and maternal–fetal medicine specialists. Pediatrics, 130(6), e1534–e1540. doi:10.1542/peds.2012-1352.
Bruner, J. P., & Tulipan, N. (2004). Tell the truth about spina bifida. Ultrasound in Obstetrics and Gynecology, 24(6), 595–596. doi:10.1002/uog.1742.
Chambers, M. (1984, December 16). Advocates for the right to life. The New York Times Magazine.
Chervenak, F. A., & McCullough, L. B. (2002). A comprehensive ethical framework for fetal research and its application to fetal surgery for spina bifida. American Journal of Obstetrics and Gynecology, 187(1), 10–14.
Cohen, A. R., Couto, J., Cummings, J. J., Johnson, A., Joseph, G., Kaufman, B. A., et al. (2014). Position statement on fetal myelomeningocele repair. American Journal of Obstetrics and Gynecology, 210(2), 107–111. doi:10.1016/j.ajog.2013.09.016.
de Jong, T. H. (2008). Deliberate termination of life of newborns with spina bifida, a critical reappraisal. Childs Nervous System, 24(1), 13–28; discussion 29–56. doi:10.1007/s00381-007-0478-3.
Domrose, C. M., Bremer, S., Buczek, C., Geipel, A., Berg, C., Gembruch, U., et al. (2016). Termination of pregnancy after prenatal diagnosis of spina bifida: A German perspective. Archives of Gynecology and Obstetrics, 294(4), 731–737. doi:10.1007/s00404-016-4032-y.
Elliott, C. (1999). A philosophical disease: Bioethics, culture, and identity. New York: Routledge.
Fiks, A. G., Hughes, C. C., Gafen, A., Guevara, J. P., & Barg, F. K. (2011). Contrasting parents’ and pediatricians’ perspectives on shared decision-making in ADHD. Pediatrics, 127(1), e188–e196. doi:10.1542/peds.2010-1510.
Fiks, A. G., & Jimenez, M. E. (2010). The promise of shared decision-making in paediatrics. Acta Paediatrica, 99(10), 1464–1466. doi:10.1111/j.1651-2227.2010.01978.x.
Fletcher, J. M., & Brei, T. J. (2010). Introduction: Spina bifida—A multidisciplinary perspective. Developmental Disabilities Research Reviews, 16(1), 1–5. doi:10.1002/ddrr.101.
Freeman, J. M. (1984). Early management and decision making for the treatment of myelomeningocele: A critique. Pediatrics, 73(4), 564–566.
Freeman, J. M. (1986). Making decisions for the severely handicapped newborn. Journal of Health Politics, Policy and Law, 11(2), 285–296.
Freeman, J. (1998). Changing ethical issues in the treatment of spina bifida: A personal odyssey. Mental Retardation and Developmental Disabilities Research Reviews, 4(4), 302–307.
Freeman, J. M. (2004). On learning humility: A thirty-year journey. Hastings Center Report, 34(3), 13–16.
Freeman, J. M. (2013). Life with spina bifida: The role of quality of life in decision-making. Journal of Pediatrics, 162(5), 894–895. doi:10.1016/j.jpeds.2012.11.065.
Godolphin, W. (2009). Shared decision-making. Healthcare Quarterly, 12(Spec No Patient), e186–e190.
Gross, R. H., Cox, A., Tatyrek, R., Pollay, M., & Barnes, W. A. (1983). Early management and decision making for the treatment of myelomeningocele. Pediatrics, 72(4), 450–458.
Jacobs, P., & McDermott, S. (1989). Family caregiver costs of chronically ill and handicapped children: Method and literature review. Public Health Reports, 104(2), 158–163.
Johnson, K. L., Dudgeon, B., Kuehn, C., & Walker, W. (2007). Assistive technology use among adolescents and young adults with spina bifida. American Journal of Public Health, 97(2), 330–336. doi:10.2105/AJPH.2004.050955.
Kleinman, A. (1988). The illness narratives: Suffering, healing, and the human condition. New York: Basic Books.
Liptak, G. S., & El Samra, A. (2010). Optimizing health care for children with spina bifida. Developmental Disabilities Research Reviews, 16(1), 66–75. doi:10.1002/ddrr.91.
Lorber, J. (1971). Results of treatment of myelomeningocele: An analysis of 524 unselected cases, with special reference to possible selection for treatment. Developmental Medicine and Child Neurology, 13(3), 279–303.
Lorber, J. (1973). Early results of selective treatment of spina bifida cystica. British Medical Journal, 4(5886), 201–204.
Lorber, J., & Salfield, S. A. (1981). Results of selective treatment of spina bifida cystica. Archives of Disease in Childhood, 56(11), 822–830.
Mansfield, C., Hopfer, S., & Marteau, T. M. (1999). Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: A systematic literature review. European Concerted Action: DADA (Decision-making after the diagnosis of a fetal abnormality). Prenatal Diagnosis, 19(9), 808–812.
McClone, D. G. (1984). Care of infants with myelomeningocele. Pediatrics, 74(1), 163–164.
Oakeshott, P., & Hunt, G. M. (2003). Long-term outcome in open spina bifida. British Journal of General Practice, 53(493), 632–636.
Paige, C., & Karnofsky, E. B. (1986). The antiabortion movement and Baby Jane Doe. Journal of Health Politics, Policy and Law, 11(2), 255–269.
Parker, S. E., Mai, C. T., Canfield, M. A., Rickard, R., Wang, Y., Meyer, R. E., et al. (2010). Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Research. Part A, Clinical and Molecular Teratology, 88(12), 1008–1016. doi:10.1002/bdra.20735.
Pruitt, L. J. (2012). Living with spina bifida: A historical perspective. Pediatrics, 130(2), 181–183. doi:10.1542/peds.2011-2935.
Sawin, K. J., Liu, T., Ward, E., Thibadeau, J., Schechter, M. S., Soe, M. M., et al. (2015). The National Spina Bifida Patient Registry: Profile of a large cohort of participants from the first 10 clinics. The Journal of Pediatrics, 166(2), 444–450.e1. doi:10.1016/j.jpeds.2014.09.039.
Sharrard, W. J., Zachary, R. B., & Lorber, J. (1967). The long-term evaluation of a trial of immediate and delayed closure of spina bifida cystica. Clinical Orthopaedics and Related Research, 50, 197–201.
Shurtleff, D. B., Hayden, P. W., Loeser, J. D., & Kronmal, R. A. (1974). Myelodysplasia: Decision for death or disability. New England Journal of Medicine, 291(19), 1005–1011. doi:10.1056/NEJM197411072911905.
Towle, A., & Godolphin, W. (1999). Framework for teaching and learning informed shared decision making. British Medical Journal, 319(7212), 766–771.
Trudell, A. S., & Odibo, A. O. (2014). Diagnosis of spina bifida on ultrasound: Always termination? Best Practices and Research: Clinical Obstetrics and Gynaecology, 28(3), 367–377. doi:10.1016/j.bpobgyn.2013.10.006.
Venes J. L. (1984). Care of infants with myelomeningocele. Pediatrics, 74(1), 162–163.
Verhagen, E., & Sauer, P. J. (2005). The Groningen protocol—Euthanasia in severely ill newborns. New England Journal of Medicine, 352(10), 959–962. doi:10.1056/NEJMp058026.
Verhoef, M., Post, M. W., Barf, H. A., van Asbeck, F. W., Gooskens, R. H., & Prevo, A. J. (2007). Perceived health in young adults with spina bifida. Developmental Medicine and Child Neurology, 49(3), 192–197. doi:10.1111/j.1469-8749.2007.00192.x.
Williams, J., Mai, C. T., Mulinare, J., Isenburg, J., Flood, T. J., Ethen, M., et al. (2015). Updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011. Morbidity and Mortality Weekly Report, 64(1), 1–5.
World Health Organization. (2002). International classification of functioning, disability and health (ICF). Geneva: World Health Organization.
Young, N. L., Sheridan, K., Burke, T. A., Mukherjee, S., & McCormick, A. (2013). Health outcomes among youths and adults with spina bifida. Journal of Pediatrics, 162(5), 993–998. doi:10.1016/j.jpeds.2012.10.042.
Zachary, R. B. (1976). The neonatal surgeon. British Medical Journal, 2(6040), 866–869.
Zachary, R. B. (1977). Life with spina bifida. British Medical Journal, 2(6100), 1460–1462.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Levin-Decanini, T., Houtrow, A. & Katz, A. The Evolution of Spina Bifida Treatment Through a Biomedical Ethics Lens. HEC Forum 29, 197–211 (2017). https://doi.org/10.1007/s10730-017-9327-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10730-017-9327-2